MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$92,311K
Free Cash flow
-$7,584K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from convertible senior...
Proceeds from maturities of mark...
Loss on revenue interest liabili...
Others
Negative Cash Flow Breakdown
Revenue interest liability extin...
Purchases of marketable securiti...
Net loss
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-39,941
-20,015
-13,579
9,545
Depreciation expense
3,272
3,418
3,766
3,977
Noncash lease expense
1,126
1,448
1,372
1,350
Share-based compensation expense
11,119
11,928
12,720
13,257
Intangible assets amortization
423
419
429
428
Investment amortization
112
136
288
516
Impairment of long-lived assets
0
347
0
0
Write-off of inventory
12
-10
563
-
Inventory reserve
-
-
-
-6
Revenue interest purchase agreement and convertible senior notes interest
6,789
-
-
-
Noncash interest expense
-
-
-
-1,728
Revenue interest purchase agreement interest
-
655
2,071
-
Loss on revenue interest liability extinguishment
23,733
-
-
-
Other Noncash Income Expense
120
-14
-101
-434
Accounts receivable, net
1,198
-2,050
5,544
536
Inventory
-561
1,315
10
1,347
Prepaid expenses and other current assets
1,702
824
-799
2,524
Accounts payable and accrued liabilities
1,010
-7,512
1,165
5,896
Operating lease right-of-use assets and liabilities
-2,005
-2,600
-2,655
-2,567
Deferred revenue
3,659
4,004
3,657
-32,790
Increase Decrease In Other Operating Capital Net
103
98
-137
0
Net cash used in operating activities
-6,400
-9,537
2,055
-7,127
Purchases of property and equipment
1,184
796
636
409
Purchases of marketable securities
82,725
38,863
46,731
33,191
Proceeds from maturities of marketable securities
40,432
48,802
39,115
50,883
Net cash (used in) provided by investing activities
-43,477
9,143
-8,252
17,283
Proceeds from exercise of stock options
5,382
5,025
9,134
1,684
Proceeds from capital contributions for digital biotechnologies, inc
0
2,475
12,524
-
Revenue interest liability extinguishment
148,108
-
-
-
Proceeds from convertible senior notes, net of issuance costs
335,513
-
-
-
Repurchase of common stock
25,000
-
-
-
Purchase of capped calls
25,599
-
-
-
Net cash provided by financing activities
142,188
7,500
21,658
1,684
Net increase (decrease) in cash, cash equivalents and restricted cash
92,311
7,106
15,461
11,840
Cash, cash equivalents and restricted cash at beginning of year
80,290
73,184
57,723
50,817
Cash, cash equivalents and restricted cash at end of period
172,601
80,290
73,184
57,723
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from
convertible senior notes,...
$335,513K
Proceeds from exercise of
stock options
$5,382K
(-23.78%↓ Y/Y)
Net cash provided by
financing activities
$142,188K
(1913.71%↑ Y/Y)
Canceled cashflow
$198,707K
Net increase
(decrease) in cash, cash...
$92,311K
(1970.92%↑ Y/Y)
Canceled cashflow
$49,877K
Revenue interest
liability extinguishment
$148,108K
Purchase of capped calls
$25,599K
Repurchase of common stock
$25,000K
Proceeds from maturities
of marketable...
$40,432K
(-69.51%↓ Y/Y)
Loss on revenue
interest liability...
$23,733K
Share-based compensation
expense
$11,119K
(-56.41%↓ Y/Y)
Deferred revenue
$3,659K
(148.07%↑ Y/Y)
Depreciation expense
$3,272K
(-61.01%↓ Y/Y)
Noncash lease expense
$1,126K
(-57.38%↓ Y/Y)
Accounts payable and
accrued liabilities
$1,010K
(115.79%↑ Y/Y)
something is missing
$655K
Inventory
-$561K
(-56.27%↓ Y/Y)
Intangible assets
amortization
$423K
(-49.76%↓ Y/Y)
Write-off of inventory
$12K
Net cash (used in)
provided by investing...
-$43,477K
(-250.34%↓ Y/Y)
Net cash used in
operating activities
-$6,400K
(84.36%↑ Y/Y)
Canceled cashflow
$40,432K
Canceled cashflow
$45,570K
Purchases of marketable
securities
$82,725K
(-18.73%↓ Y/Y)
Net loss
-$39,941K
(27.93%↑ Y/Y)
Purchases of property and
equipment
$1,184K
(-38.14%↓ Y/Y)
Revenue interest
purchase agreement and...
$6,789K
Operating lease
right-of-use assets and...
-$2,005K
(61.66%↑ Y/Y)
Prepaid expenses and
other current assets
$1,702K
(21175.00%↑ Y/Y)
Accounts receivable, net
$1,198K
(-53.31%↓ Y/Y)
Other Noncash Income
Expense
$120K
(379.07%↑ Y/Y)
Investment amortization
$112K
(-93.44%↓ Y/Y)
Increase Decrease In
Other Operating...
$103K
(2160.00%↑ Y/Y)
Buy us a coffee
Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (ADPT)